HealthHIV HIV Prevention Certified Provider Program


The HealthHIV HIV Prevention Certified Provider™ Certification Program is an online, self-paced CME accredited certification program composed of seven modules in HIV prevention detailing the pertinent clinical and practice information that clinicians need to effectively employ HIV prevention interventions.

Upon successful completion of this program, participants earn a certification recognizing their designation as an HIV Prevention Certified Provider (HIVPCP) and receive a listing in the national online directory alongside thousands of other HIV Prevention Certified Providers™. The curriculum is updated annually and more frequently as needed, based on approval of new biomedical interventions and the release of evidence-based practices.

Additional PrEP navigation training is available through HealthHIV’s HIV PrEP Navigation Certification (HIVPNC) Program, which is the only certification program in PrEP navigation offered to providers and allied health professionals to deliver inclusive, affirming PrEP navigation services backed by current data and clinical best practice.


Target Audience This activity is intended for providers (physicians, PAs, NPs, nurses, pharmacists), allied health professionals (navigators, case managers, social workers, disease intervention specialists, health educators) and other healthcare professionals involved in the care of patients at risk for acquiring HIV.  
  • Media: Enduring Material
  • Release date: April 1, 2024
  • Expiration date: April 1, 2025
  • Time to Complete: 60 minutes per module

Educational Objectives

After completing this activity, the participant should be better able to:

  • Determine patient risk of HIV infection and eligibility for HIV prevention strategies, such as PrEP, by initiating a patient-provider dialogue regarding sexual health and behavior to overcome HIV stigma
  • Recognize population-based considerations for HIV prevention and/or PrEP (eg people experiencing homelessness, persons of child-bearing age, youth, and older adults)
  • Facilitate access to HIV prevention strategies by effectively engaging with and connecting patients to resources throughout the PrEP care continuum (e.g., HIV testing,PrEP initiation and adherence, medical home)
  • Differentiate current and emerging HIV PrEP options based on the latest guidelines regarding clinical use as well as recent evidence to support initiation, monitoring, and retention of diverse patients in HIV prevention services
Program Agenda

  • Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies

  • Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative

  • Module 3: Biomedical Strategies for Preventing HIV

  • Module 4: Enhancing Cultural Humility and Understanding Barriers to Care

  • Module 5: PrEP Adherence & Persistence

  • Module 6: Population-Based Considerations for PrEP

  • Module 7: State of HIV Prevention and PrEP in 2024: Certification Maintenance for HIVPCPs

Accreditation, Credit, and Support

Round MLI logoHealthHIV logoAll modules are certified and participants can earn up to 7.0 credits/contact hours (CME, MOC, NCPD, CPE, AAPA, ASWB) for completion of the certification program (7 modules).


Joint accreditation logoIn support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Continuing Medical Education Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

ECMEC® Credit The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)™ into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).

Physician Associate Credit Designation Statement Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until April 1, 2025. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

Please see below for the assigned pharmacology contact hour per module.
.  

Hrs.

Module

none

Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies

none

Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative

1.0

Module 3: Biomedical Strategies for Preventing HIV

none

Module 4: Enhancing Cultural Humility and Understanding Barriers to Care

0.66

Module 5: PrEP Adherence & Persistence

none

Module 6: Population-Based Considerations for PrEP

none

Module 7: State of HIV Prevention and PrEP in 2024: Certification Maintenance for HIVPCPs


Continuing Pharmacy Education Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge Please see each module for the corresponding UAN number.

Social Worker Continuing Education

ACE: approved continuing educationAs a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.


Support Statement

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.

Disclosure & Conflict of Interest Policy Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Disclosure of Unlabeled Use This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).

For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.


About This Activity

Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.


Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies

Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies

Faculty: Jonathan Appelbaum, MD, FACP, AAHIVS


Course Description:

This course provides an overview on HIV in the U.S., touching on history, disparities, policies, and public health strategies, while emphasizing the importance of the HIV Prevention certification.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Describe the role of the HIV Prevention certification

  • Review current epidemiology of HIV in the United States

  • Describe disparities of HIV infection and access to prevention methods

  • Identify public health strategies and clinical interventions for HIV prevention

UAN#: JA0007322-9999-24-020-H01-P


Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative

Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative

Faculty: Jonathan Appelbaum, MD, FACP, AAHIVS


Course Description:

This course provides information on screening and diagnosing HIV, risk identification, short behavioral interventions, a status-neutral care approach for HIV services, and the importance of sexually transmitted infection screening and HIV treatment.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Explain the provision of HIV-related services through a status neutral care approach

  • Explain how to identify HIV risk

  • Identify appropriate short behavioral interventions

  • Describe screening for and diagnosing HIV infection

UAN#: JA0007322-9999-24-021-H01-P


Module 3: Biomedical Strategies for Preventing HIV

Module 3: Biomedical Strategies for Preventing HIV

Faculty: Brian Wood, MD


Course Description:

This course provides an outline for preventing HIV through PEP, PrEP, and TasP, covering clinical basics, research findings, CDC's guidance on PrEP, and emerging modalities.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Describe the clinical basics of prescribing PEP

  • Describe the clinical basics of prescribing PrEP

  • Discuss CDC’s guidance on oral and injectable PrEP

UAN#: JA0007322-9999-24-022-H01-P

Module 4: Enhancing Cultural Humility and Understanding Barriers to Care

Module 4: Enhancing Cultural Humility and Understanding Barriers to Care

Faculty: Aniruddha Hazra, MD


Course Description:

This course provides a review of the HIV care continuum, impact of intersectional stigma on risk, cultural humility, trauma-informed care, and resources to mitigate financial barriers for clients.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Discuss the role of intersectional stigma, discrimination, trauma, and social determinants of health in HIV risk

  • Explain cultural humility, the role it plays in providing HIV care, and overcoming barriers to care

  • Describe trauma-informed care and its importance in HIV treatment and prevention

  • Introduce resources to mitigate financial barriers for clients

UAN#: JA0007322-9999-24-023-H01-P


Module 5: PrEP Adherence & Persistence

Module 5: PrEP Adherence & Persistence

Faculty: Roger Bedimo, MD, MS, FACP


Course Description:

This course provides insight on vulnerable populations with PrEP disparities, impact of SDOH and barriers to PrEP, navigation models for access, and provider strategies for supporting adherence.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Describe the facilitators and challenges that impact PrEP uptake and adherence

  • Review strategies to support patient adherence and education

  • Describe considerations for starting, switching, and stopping PrEP

UAN#: JA0007322-9999-24-024-H01-P


Module 6: Population-Based Considerations for PrEP

Module 6: Population-Based Considerations for PrEP

Faculty: Melissa Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP


Course Description:

This course provides information on population-based considerations for PrEP, including the role of PrEP and TASP with family planning, health models to improve PrEP access, and combination HIV and STI treatment and prevention strategies.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Identify populations vulnerable to HIV infection who also experience disparities around PrEP

  • Review considerations for providing PrEP in populations with highest HIV incidence

  • Describe service delivery models that improve access to PrEP

UAN#: JA0007322-9999-24-025-H01-P



Module 7: State of HIV Prevention and PrEP in 2024: Certification Maintenance for HIVPCPs

Module 7: State of HIV Prevention and PrEP in 2024: Certification Maintenance for HIVPCPs

Faculty: Monica Gandhi, MD, MPH


Course Description:

This course provides an update on the current state of the HIV epidemic, key biomedical advances in HIV prevention, and evidence-based approaches to HIV prevention.

Educational Objectives

Upon completion of this activity, participants will be better able to:

• Describe current HIV epidemiologic data and PrEP use-to-need data

• Identify considerations for implementing long-acting HIV prevention in clinical settings

• Review forthcoming biomedical advances in HIV and STI prevention

UAN#: JA0007322-9999-24-026-H01-P

Final Certificate and Toolkit 2024

Final Certificate and Toolkit

After you have completed all seven HIVPCP modules, select this module to receive a final certificate and confirm your HIVPCP™ certification.

Once you obtain your certificate, you can register for the national database and access your toolkit materials including an e-mail signature, social media assets, office posters, and palm cards.


Maintenance of HIVPCP™ Certification for Existing HIVPCPs

For those certified in the past year, (between April 1, 2023 to March 26, 2024), please complete Module 7 to fulfill the updated knowledge gap requirement to maintain your HIVPCP™ certification. Upon completion of Module 7, please select this module to receive your extended certification.


Participants may earn up to 7.0 credits/ contact hours (CME, MOC, NCPD, CPE, AAPA, ASWB)